OPTING OUT: LIABILITY AND POLICY IMPLICATIONS OF ELIMINATING THE MEDICARE CRNA SUPERVISION REQUIREMENT

By Poirier Nicole  

Journal of Legal Medicine, Vol. 25, Iss. 2, 2004-06 ,pp. : 229-248

Taylor & Francis Ltd

Access to resources Recommend Favorite

Using Race in Clinical Research to Develop Tailored Medications Is the FDA Encouraging Discrimination or Eliminating Traditional Disparities in Health Care for African Americans?

By Ruel Michael  

Journal of Legal Medicine, Vol. 27, Iss. 2, 2006-06 ,pp. : 225-241

Taylor & Francis Ltd

Access to resources Recommend Favorite

Commoditization of PACS and the Opportunity for Disruptive Innovation

By Reiner Bruce  

Journal of Digital Imaging, Vol. 26, Iss. 2, 2013-04 ,pp. : 143-146

Springer Publishing Company

Access to resources Recommend Favorite

Is Android or iPhone the Platform for Innovation in Imaging Informatics

By Shih George  

Journal of Digital Imaging, Vol. 23, Iss. 1, 2010-02 ,pp. : 2-7

Springer Publishing Company

Access to resources Recommend Favorite

Innovation Opportunities in Critical Results Communication: Theoretical Concepts

By Reiner Bruce  

Journal of Digital Imaging, Vol. 26, Iss. 4, 2013-08 ,pp. : 605-609

Springer Publishing Company

Access to resources Recommend Favorite